Contractor intelligence · computed from public award records
MINAPHARM PHARMACEUTICALS
- Awards won
- 37
- Known value
- USD 96K
- First award
- 11 Nov 2018
- Most recent
- 14 Nov 2018
Wins by funder
| Funder | Awards | Known value | Most recent |
|---|---|---|---|
| World Bank | 37 | USD 96K | 14 Nov 2018 |
Where the work is
EG · 37
Sources
The most recent award records behind the figures above. Every number on this page is computed from records like these — nothing is estimated or editorial.
- all technical offers are acceptable for Ribavirin drugs · 14 Nov 2018 · USD 3K · World Bank
- all technical offers are accepted for The Ribavirin drugs · 12 Nov 2018 · USD 3K · World Bank
- all technical offers are acceptable for Ribavirin drugs · 12 Nov 2018 · USD 3K · World Bank
- all technical offers are accepted for The Ribavirin drugs · 12 Nov 2018 · USD 3K · World Bank
- all technical offers are accepted for The Ribavirin drugs · 12 Nov 2018 · USD 3K · World Bank
- all technical offers are accepted for The Ribavirin drugs · 12 Nov 2018 · USD 3K · World Bank
- The Ribavirin drugs were awarded to MINAPHARM PHARMACEUTICALS co as the offers are technically acceptable and the lowest offered prices · 12 Nov 2018 · USD 3K · World Bank
- all technical offers are acceptable The Ribavirin drugs · 12 Nov 2018 · USD 3K · World Bank
- all technical offers are accepted for The Ribavirin drugs · 12 Nov 2018 · USD 3K · World Bank
- all technical offers are accepted for The Ribavirin drugs · 12 Nov 2018 · USD 3K · World Bank
- all technical offers are accepted for The Ribavirin drugs · 12 Nov 2018 · USD 3K · World Bank
- all technical offers are accepted for The Ribavirin drugs · 11 Nov 2018 · USD 3K · World Bank
- all technical offers are accepted for The Ribavirin drugs · 11 Nov 2018 · USD 3K · World Bank
- all technical offers are accepted for The Ribavirin drugs · 11 Nov 2018 · USD 3K · World Bank
- all technical offers are accepted for The Ribavirin drugs · 11 Nov 2018 · USD 3K · World Bank
- all technical offers are accepted for The Ribavirin drugs · 11 Nov 2018 · USD 3K · World Bank
- all technical offers are acceptable for Ribavirin drugs · 11 Nov 2018 · USD 3K · World Bank
- all technical offers are acceptable for Ribavirin drugs · 11 Nov 2018 · USD 3K · World Bank
- all technical offers are acceptable for Ribavirin drugs · 11 Nov 2018 · USD 3K · World Bank
- all technical offers are acceptable for Ribavirin drugs · 11 Nov 2018 · USD 3K · World Bank
Method
Computed from 37 award records ingested from official disclosure sources (World Bank, Inter-American Development Bank, and published contract-award notices). Values are shown in USD where the source published one; entity identity is resolved conservatively and reviewed. GLODA is not affiliated with any funder or contractor shown. Last computed 15 Sept 2026.